Mexico City — President Claudia Sheinbaum announced Monday that Mexico has signed an agreement with pharmaceutical companies Birmex, Liomont and Moderna to develop vaccines against dengue and cancer.
“There will be joint scientific research development by Mexican researchers to develop other vaccines that interest us, such as against dengue and even against cancer,” the president said in a video shared on her social media accounts.
Sheinbaum detailed that the agreement involves Mexico’s Health Ministry and aims to position the country as a scientific power. She noted that Moderna is one of the global companies that produces mRNA vaccines against COVID-19.
More Politics
- Strawberry Dumping Ruling Threatens Nearly 5,000 Mexican Producers
- Court Rejects Third Injunction Bid by Former Playa del Carmen Mayor
- Maya Communities Reject Indigenous Law Consultation as a “Simulation”
- Mayor of Lázaro Cárdenas Fires Fire Chief Over Unpaid Stipends
- PAN Quintana Roo Denies Being ‘Sold’ to Ruling Party, Prepares for 2027
